Lupin Pharmaceuticals, Inc. recalls Lupin — Irbesartan and Hydrochlorothiazide Tablets USP, 150mg/12.5 mg and 300mg/12.5 mg
- Recall date
- October 14, 2021
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Lupin Pharmaceuticals, Inc., Lupin
Why it was recalled
API batches above the specification limit for the impurity, N-nitrosoirbesartan — Impurity
What was recalled
Irbesartan and Hydrochlorothiazide Tablets USP, 150mg/12.5 mg and 300mg/12.5 mg
Read the official recall notice →
Get recall alerts
Free email alert whenever Lupin Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Lupin Pharmaceuticals, Inc., Lupin